Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Skin, hair, and nail changes can help detect eating disorders early.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.